180 related articles for article (PubMed ID: 18781181)
1. Prognostic value of protein tyrosine kinase 6 (PTK6) for long-term survival of breast cancer patients.
Aubele M; Walch AK; Ludyga N; Braselmann H; Atkinson MJ; Luber B; Auer G; Tapio S; Cooke T; Bartlett JM
Br J Cancer; 2008 Oct; 99(7):1089-95. PubMed ID: 18781181
[TBL] [Abstract][Full Text] [Related]
2. Impact of protein tyrosine kinase 6 (PTK6) on human epidermal growth factor receptor (HER) signalling in breast cancer.
Ludyga N; Anastasov N; Gonzalez-Vasconcellos I; Ram M; Höfler H; Aubele M
Mol Biosyst; 2011 May; 7(5):1603-12. PubMed ID: 21380407
[TBL] [Abstract][Full Text] [Related]
3. PTK (protein tyrosine kinase)-6 and HER2 and 4, but not HER1 and 3 predict long-term survival in breast carcinomas.
Aubele M; Auer G; Walch AK; Munro A; Atkinson MJ; Braselmann H; Fornander T; Bartlett JM
Br J Cancer; 2007 Mar; 96(5):801-7. PubMed ID: 17299391
[TBL] [Abstract][Full Text] [Related]
4. Mammary gland specific expression of Brk/PTK6 promotes delayed involution and tumor formation associated with activation of p38 MAPK.
Lofgren KA; Ostrander JH; Housa D; Hubbard GK; Locatelli A; Bliss RL; Schwertfeger KL; Lange CA
Breast Cancer Res; 2011 Sep; 13(5):R89. PubMed ID: 21923922
[TBL] [Abstract][Full Text] [Related]
5. Low expression of PTK6/Brk predicts poor prognosis in patients with laryngeal squamous cell carcinoma.
Liu XK; Zhang XR; Zhong Q; Li MZ; Liu ZM; Lin ZR; Wu D; Zeng MS
J Transl Med; 2013 Mar; 11():59. PubMed ID: 23497344
[TBL] [Abstract][Full Text] [Related]
6. Effects of simultaneous knockdown of HER2 and PTK6 on malignancy and tumor progression in human breast cancer cells.
Ludyga N; Anastasov N; Rosemann M; Seiler J; Lohmann N; Braselmann H; Mengele K; Schmitt M; Höfler H; Aubele M
Mol Cancer Res; 2013 Apr; 11(4):381-92. PubMed ID: 23364537
[TBL] [Abstract][Full Text] [Related]
7. Additive impact of HER2-/PTK6-RNAi on interactions with HER3 or IGF-1R leads to reduced breast cancer progression in vivo.
Falkenberg N; Anastasov N; Höfig I; Bashkueva K; Lindner K; Höfler H; Rosemann M; Aubele M
Mol Oncol; 2015 Jan; 9(1):282-94. PubMed ID: 25241146
[TBL] [Abstract][Full Text] [Related]
8. PTEN is a protein phosphatase that targets active PTK6 and inhibits PTK6 oncogenic signaling in prostate cancer.
Wozniak DJ; Kajdacsy-Balla A; Macias V; Ball-Kell S; Zenner ML; Bie W; Tyner AL
Nat Commun; 2017 Nov; 8(1):1508. PubMed ID: 29142193
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of PTK6 (breast tumor kinase) protein--a prognostic factor for long-term breast cancer survival--is not due to gene amplification.
Aubele M; Vidojkovic S; Braselmann H; Ritterswürden D; Auer G; Atkinson MJ; Tapio S; Höfler H; Rauser S; Bartlett JM
Virchows Arch; 2009 Aug; 455(2):117-23. PubMed ID: 19621240
[TBL] [Abstract][Full Text] [Related]
10. PTK6/BRK is expressed in the normal mammary gland and activated at the plasma membrane in breast tumors.
Peng M; Emmadi R; Wang Z; Wiley EL; Gann PH; Khan SA; Banerji N; McDonald W; Asztalos S; Pham TN; Tonetti DA; Tyner AL
Oncotarget; 2014 Aug; 5(15):6038-48. PubMed ID: 25153721
[TBL] [Abstract][Full Text] [Related]
11. In situ quantification of HER2-protein tyrosine kinase 6 (PTK6) protein-protein complexes in paraffin sections from breast cancer tissues.
Aubele M; Spears M; Ludyga N; Braselmann H; Feuchtinger A; Taylor KJ; Lindner K; Auer G; Stering K; Höfler H; Schmitt M; Bartlett JM
Br J Cancer; 2010 Aug; 103(5):663-7. PubMed ID: 20700126
[TBL] [Abstract][Full Text] [Related]
12. PTK6 inhibition promotes apoptosis of Lapatinib-resistant Her2(+) breast cancer cells by inducing Bim.
Park SH; Ito K; Olcott W; Katsyv I; Halstead-Nussloch G; Irie HY
Breast Cancer Res; 2015 Jun; 17(1):86. PubMed ID: 26084280
[TBL] [Abstract][Full Text] [Related]
13. Tyrosine phosphorylation of sam68 by breast tumor kinase regulates intranuclear localization and cell cycle progression.
Lukong KE; Larocque D; Tyner AL; Richard S
J Biol Chem; 2005 Nov; 280(46):38639-47. PubMed ID: 16179349
[TBL] [Abstract][Full Text] [Related]
14. PTK6 inhibits down-regulation of EGF receptor through phosphorylation of ARAP1.
Kang SA; Lee ES; Yoon HY; Randazzo PA; Lee ST
J Biol Chem; 2010 Aug; 285(34):26013-21. PubMed ID: 20554524
[TBL] [Abstract][Full Text] [Related]
15. An intramolecular interaction between SH2-kinase linker and kinase domain is essential for the catalytic activity of protein-tyrosine kinase-6.
Kim HIe; Lee ST
J Biol Chem; 2005 Aug; 280(32):28973-80. PubMed ID: 15961400
[TBL] [Abstract][Full Text] [Related]
16. Small molecule inhibitors reveal PTK6 kinase is not an oncogenic driver in breast cancers.
Qiu L; Levine K; Gajiwala KS; Cronin CN; Nagata A; Johnson E; Kraus M; Tatlock J; Kania R; Foley T; Sun S
PLoS One; 2018; 13(6):e0198374. PubMed ID: 29879184
[TBL] [Abstract][Full Text] [Related]
17. The expression and prognostic value of protein tyrosine kinase 6 in early-stage cervical squamous cell cancer.
Wang XJ; Xiong Y; Ma ZB; Xia JC; Li YF
Chin J Cancer; 2016 Jun; 35(1):54. PubMed ID: 27311570
[TBL] [Abstract][Full Text] [Related]
18. Breast tumor kinase/protein tyrosine kinase 6 (Brk/PTK6) activity in normal and neoplastic biliary epithelia.
Mizuguchi Y; Specht S; Isse K; Sasatomi E; Lunz JG; Takizawa T; Demetris AJ
J Hepatol; 2015 Aug; 63(2):399-407. PubMed ID: 25770659
[TBL] [Abstract][Full Text] [Related]
19. Simultaneous over-expression of the Her2/neu and PTK6 tyrosine kinases in archival invasive ductal breast carcinomas.
Born M; Quintanilla-Fend L; Braselmann H; Reich U; Richter M; Hutzler P; Aubele M
J Pathol; 2005 Apr; 205(5):592-6. PubMed ID: 15685689
[TBL] [Abstract][Full Text] [Related]
20. Hsp90 rescues PTK6 from proteasomal degradation in breast cancer cells.
Kang SA; Cho HS; Yoon JB; Chung IK; Lee ST
Biochem J; 2012 Oct; 447(2):313-20. PubMed ID: 22849407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]